Back to MA Mather Group, LLC

MRNAMRNA

Showing 9 of 16 quarters

Position history for MAMather Group, LLC's holdings in Moderna, Inc.

Yes. Mather Group holds 7,756 shares of MRNA (Moderna), worth $1.5M, as of its Q3 2026 13F filing. It increased the position by 152 shares (+2.0%) from Q2 2026. Mather Group has held MRNA since Q1 2024, across 11 quarterly 13F filings.

Current Value

$1.5M

Current Shares

7,756

Total Value Change

+$1.4M

Total Shares Change

+6,475

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
7,756
+2.0%
$1.5M0.0%$192.57
26
2026-Q2
Decreased
7,604
-0.5%
$532,5080.0%$70.03
0
2026-Q1
Increased
7,645
+7.8%
$388,3660.0%$50.80
26
2025-Q4
Decreased
7,094
-32.4%
$209,2020.0%$29.49
0
2025-Q3
Decreased
10,496
-3.8%
$271,1120.0%$25.83
0
2025-Q2
Increased
10,914
+181.4%
$301,1170.0%$27.59
38
2025-Q1
Increased
3,879
+472.1%
$109,9740.0%$28.35
35
2024-Q4
Decreased
678
-47.1%
$28,1910.0%$41.58
0
2024-Q3
Increased
1,281
+25.7%
$85,6090.0%$65.75
26

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used